GN
Gilmore Neil O'Neill sold $51K of EDIT stock
Gilmore Neil O'Neill, CEO of Editas Medicine, Inc. (EDIT), sold 21,164 shares of EDIT stock worth $51K, per an SEC Form 4 filed Nov 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 11, 2026, 2 days before it was made public.
EDIT has moved -8.8% since the trade date, from $2.38 to $2.17 (Nov 13, 2026 close).
- Traded
- Nov 11, 2026
- Disclosed
- Nov 13, 2026
- Filing delay
- 2 days
- Price since
- -8.8%
- Role
- CEO
- Source
- SEC Form 4